Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Notice of Results Presentations

27 Apr 2023 07:00

RNS Number : 6168X
Directa Plus PLC
27 April 2023
 

27 April 2023

 

Directa Plus plc

("Directa Plus", the "Company" or the "Group")

 

 

Notice of Results Presentations

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene nanoplatelets based products for use in consumer and industrial markets, is pleased to announce that following the release of its Final Results on 10 May 2023, management will host a live virtual presentation and Q&A for analysts at 9am on the morning on results, and a live virtual presentation and Q&A for retail investors on 12 May 2023 at 1.30pm.

 

Both presentations will be given by Giulio Cesareo - Chief Executive Officer, and Giorgio Bonfanti - Chief Financial Officer.

 

Questions can be submitted at any time during the live presentations.

 

A recording of the presentation will be made available on the Company's website following the conclusion of the investor presentation.

 

Analyst Presentation

 

To register to attend, please email directaplus@almapr.co.uk

 

Retail Investor Presentation

 

To register to attend, please use the following link: https://www.investormeetcompany.com/directa-plus-plc/register-investor

 

 

Enquiries

 

Directa Plus plc

 

+39 02 36714458

Giulio Cesareo, CEO

 

www.directa-plus.com

Giorgio Bonfanti, CFO

 

 

Cenkos Securities plc (Nominated Adviser and Joint Broker)

 

+44 131 220 6939

Neil McDonald

 

Adam Rae

 

 

Singer Capital Markets Securities Limited (Joint Broker)

 

+44 20 7496 3069

Rick Thompson

 

Phil Davies

 

 

Alma PR (Financial PR Adviser)

 

+44 20 3405 0205

Justine James

 

Hannah Campbell

Kinvara Verdon

 

 

Notes to Editors

 

Directa Plus (www.directa-plus.com) is one of the largest producers and suppliers of graphene-based products for use in consumer and industrial markets. The Company's graphene manufacturing capability uses proprietary patented technology based on a plasma super expansion process. Starting from natural graphite, each step of Directa Plus' production process - expansion, exfoliation and drying - creates graphene-based materials and hybrid graphene materials ready for a variety of uses and available in various forms such as powder, liquid and paste.

 

This proprietary production process uses a physical process, rather than a chemical process, to process graphite into pristine graphene nanoplatelets, which enables Directa Plus to offer a sustainable, non-toxic product, without unwanted by-products. Directa Plus' products are made of hybrid graphene materials and graphene nano-platelets. The products (marketed as G+®) have multiple applications due to their properties. These G+® products can be categorised into various families, with different products being suitable for specific practical applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and has been listed on the AIM market of the London Stock Exchange since May 2016. Directa Plus holds the Green Economy Mark from London Stock Exchange which recognises companies that contribute to the global green economy.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORPPUPGCUPWPGQ

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.